Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (9): 1018-1024.doi: 10.3736/jcim20120911

Previous Articles     Next Articles

Effects of Chinese herbal medicine Tianqi Pingchan Granule on G protein-coupled receptor kinase 6 involved in the prevention of levodopa-induced dyskinesia in rats with Parkinson disease

Na Wu1, Lu Song1, Xin-xin Yang1, Jiang-lei Wei2, Zhen-guo Liu1()   

  1. 1. Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    2. Department of Emergency, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2012-02-12 Accepted:2012-02-28 Online:2012-09-20 Published:2018-09-15
  • Contact: Zhen-guo Liu E-mail:zhenguoliu2004@yahoo.com.cn

Objective: To investigate the effects of Tianqi Pingchan (TQPC) Granule, a compound traditional Chinese herbal medicine with antitremor activity, on levodopa-induced dyskinesia and the expression of G protein-coupled receptor kinase 6 (GRK6) in rats with Parkinson disease (PD).

Methods: The hemi-Parkinsonian rat model was established by sterotaxically injecting 6-hydroxydopa (6-OHDA) to the right medial forebrain bundle. Rats with PD were randomly divided into 5 groups with 5 in each. PD group was intraperitoneally injected with vitamin C; levodopa group was intraperitoneally injected with levodopa and benserazide; low-, medium- and high-dose TQPC Granule groups were intraperitoneally injected with levodopa and benserazide and treated with different dosages of TQPC Granule by gavage for 29 d. Another 5 rats were served as control with sham-operation. The behaviors of rats were observed and classified with abnormal involuntary movement (AIM) score. The expression of GRK6 in the striate of rats was detected by immunohistochemical method and Western blotting.

Results: AIM score was increased and the expression of GRK6 protein in lesion side was decreased after the long-tern treatment with levodopa and benserazide in rats. The AIM scores of rats with PD were decreased after TGPC Granule treatment. Immunohistochemical results showed that the number of GRK6-positive cells in medium- and high-dose TQPC Granule groups was increased as compared to that in the levodopa group (P<0.05). The expression level of GRK6 protein was increased in medium-dose TQPC Granule group when compared with the levodopa group (P<0.01), which was observed by Western blotting.

Conclusion: TGPC Granule can increase the expression of GRK6, inhibit the increase of AIM, and reduce the incidence of levodopa-induced dyskinesia in rats with PD.

Key words: Parkinson’s disease;, levodopa, dyskinesia, drugs, Chinese herbal, G-protein-coupled receptor kinase 6, rats

Table 1

AIM scores in different groups ($\overline{x}$±s)"

Time Group n AIM scores
Orolingual Upper limb Axial Locomotor
2 d Levodopa 5 1.44±0.18 1.51±0.22 2.49±0.17 2.67±0.28
Low-dose TQPC Granule 5 1.51±0.17 1.58±0.19 2.42±0.16 2.62±0.23
Medium-dose TQPC Granule 5 1.40±0.19 1.56±0.28 2.51±0.22 2.71±0.34
High-dose TQPC Granule 5 1.42±0.24 1.62±0.26 2.38±0.15 2.62±0.23
8 d Levodopa 5 1.82±0.17 1.93±0.20 2.71±0.41 3.20±0.25
Low-dose TQPC Granule 5 1.89±0.21 1.91±0.19 2.76±0.41 3.16±0.20
Medium-dose TQPC Granule 5 1.56±0.18 1.76±0.16 2.58±0.29 2.93±0.19
High-dose TQPC Granule 5 1.51±0.22 1.67±0.22 2.42±0.24 2.60±0.06
15 d Levodopa 5 2.11±0.22 2.18±0.15 2.93±0.28 3.36±0.28
Low-dose TQPC Granule 5 1.84±0.17 2.09±0.12 2.71±0.37 3.09±0.24
Medium-dose TQPC Granule 5 1.47±0.14 1.71±0.22 2.69±0.24 2.84±0.19
High-dose TQPC Granule 5 1.33±0.11 1.51±0.22 2.38±0.20 2.58±0.15
22 d Levodopa 5 2.40±0.37 2.56±0.16 3.18±0.15 3.38±0.29
Low-dose TQPC Granule 5 1.96±0.20 2.13±0.14 2.62±0.28 3.11±0.21
Medium-dose TQPC Granule 5 1.49±0.13 1.69±0.20 2.29±0.13 2.67±0.11
High-dose TQPC Granule 5 1.29±0.13 1.49±0.23 2.24±0.18 2.53±0.15
29 d Levodopa 5 2.36±0.36 2.60±0.13 3.16±0.13 3.47±0.23
Low-dose TQPC Granule 5 2.04±0.13 2.13±0.20 2.76±0.26 3.24±0.14
Medium-dose TQPC Granule 5 1.33±0.21 1.67±0.18 2.33±0.16 2.56±0.14
High-dose TQPC Granule 5 1.20±0.09 1.53±0.21 2.11±0.78 2.29±0.10

Table 2

Effects of different doses of Tianqi Pingchan Granule on striatal GRK6 expression in rats with levodopa-induced PD"

Group n IOD (×103)
Lesioned side Unlesioned side
Sham 5 6.20±0.55 6.03±0.59
PD 5 4.54±0.85** 6.01±0.72
Levodopa 5 3.53±0.71 5.90±1.51
Low-dose TQPC Granule 5 4.17±1.20 5.72±1.30
Medium-dose TQPC Granule 5 4.31±0.95 6.35±1.26
High-dose TQPC Granule 5 4.88±1.24 6.03±1.14

Figure 1

Immunohistochemical method confirmed the effects of different doses of TQPC Granule on GRK6 expression in striatum of rats with PD (light microscopy, ×400) 1: Sham group; 2: PD group; 3: Levodopa group; 4: Low-dose TQPC Granule group; 5: Medium-dose TQPC Granule group; 6: High-dose TQPC Granule group. U: Unlesioned side; L: Lesioned side; PD: Parkinson disease; TQPC: Tianqi Pingchan; GRK6: G protein coupled receptor kinase 6."

Figure 2

Western blot results confirmed the effects of different doses of TQPC Granule on GRK6 expression in striatum of rats with PD 1, 2: Sham group; 3, 4: PD group; 5, 6: Levodopa group; 7, 8: Low-dose TQPC Granule group; 9, 10: Medium-dose TQPC Granule group; 11, 12: High-dose TQPC Granule group; 1, 3, 5, 7, 9, 11: Unlesioned side; 2, 4, 6, 8, 10, 12: Lesioned side. PD: Parkinson disease; TQPC: Tianqi Pingchan; GRK6: G protein coupled receptor kinase 6."

[1] Liu ZG, Qi C . Motor complications of Parkinson’s disease and its treatment strategies[J]. Zhonghua Yi Xue Za Zhi, 2009,89(35):2516-2519
刘振国, 戚辰 . 帕金森病运动并发症及其治疗策略[J]. 中华医学杂志, 2009,89(35):2516-2519
[2] Obeso JA, Rodriguez-Oroz M, Marin C, Alonso F, Zamarbide I, Lanciego JL, Rodriguez-Diaz M . The origin of motor fluctuations in Parkinson’s disease: importance of dopaminergic innervation and basal ganglia circuits[J]. Neurology, 2004,62(1 Suppl 1):S17-S30
doi: 10.1212/WNL.62.10.17A
[3] Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, Schwarz S, Axelrod JD, Cheyette BN, Simon MI, Lester HA, Schwarz J . D2 dopamine receptors colocalize regulator of G-protein signaling 9-2(RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways[J]. J Neurosci, 2005,25(8):2157-2165
doi: 10.1523/JNEUROSCI.2840-04.2005
[4] DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK . β-arrestins and cell signaling[J]. Annu Rev Physiol, 2007, 69483-510
[5] Gurevich EV, Gurevich VV . Arrestins: ubiquitous regulators of cellular signaling pathways[J]. Genome Biol, 2006,7(9):236
doi: 10.1186/gb-2006-7-9-236
[6] Wu N, Yang XX, Song L, Liu ZG . Relationship between G protein-coupled receptor kinase 6 and N-methyl-D-aspartate receptor in the mechanism study underlying motor complications in Parkinson’s disease[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2011,30(4):327-331
吴娜, 杨新新, 宋璐, 刘振国 . 帕金森病运动并发症发生机制中G蛋白偶联受体激酶6与N-甲基-D-天冬氨酸受体关系的研究[J]. 中华老年医学杂志, 2011,30(4):327-331
[7] Ba MW, Liu ZG, Kong M, Yang HQ, Chen SD, Lu GQ . The establishment and evaluation of a rat model of levodopa-induced dyskinesia[J]. Shanghai Jiao Tong Da Xue Xue Bao Yi Xue Ban, 2006, 26810-812
巴茂文, 刘振国, 孔敏, 杨红旗, 陈生弟, 陆国强 . 左旋多巴诱发帕金森病大鼠异动症模型的建立和评价[J]. 上海交通大学学报(医学版), 2006, 26810-812
[8] Bao XM. The rat brain in stereotaxic coordinates[M]. Beijing: People’s Medical Publishing House, 2005, 16-35
包新民 . 大鼠脑立体定位图谱[M]. 北京: 人民卫生出版社, 2005, 16-35
[9] Ba MW, Liu ZG, Kong M, Chen SD, Lu GQ . Relationship between motor complications of Parkinson’s disease and phosphorylated GIuR1Ser845[J]. Zhonghua Shen Jing Ke Za Zhi, 2006,39(12):822-826
巴茂文, 刘振国, 孔敏, 陈生弟, 陆国强 . 帕金森病运动并发症与谷氨酸受体亚型GluR1Ser845磷酸化关系的实验研究[J]. 中华神经科杂志, 2006,39(12):822-826
[10] Kong M, Ba MW, Liu ZG . Research progress in motor complications of Parkinson’s disease[J]. Zhonghua Yi Xue Za Zhi, 2009,89(3):210-212
孔敏, 巴茂文, 刘振国 . 帕金森病运动并发症的研究进展[J]. 中华医学杂志, 2009,89(3):210-212
[11] Nanjing University of Chinese Medicine. Dictionary of traditional Chinese drugs.2nd ed[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2006, 326-2086
南京中医药大学. 中药大辞典.第2版[M]. 上海: 上海科学技术出版社, 2006, 326-2086
[12] Yuan CX, Ye Q, Wang J, Zhang Y, Yuan CG . Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias[J]. J Chin Integr Med, 2008,6(10):1024-1028
袁灿兴, 叶青, 王洁, 张燕, 袁崇刚 . 滋补肝肾、通络解毒中药对异动症大鼠行为学及纹状体多巴胺D2受体活性的影响[J]. 中西医结合学报, 2008,6(10):1024-1028
[13] Zhang QJ, Zhang YY, Huang WY . Traditional Chinese medicine in treatment of Parkinson’s disease[J]. J Chin Integr Med, 2004,2(1):75-77
张秋娟, 张云云, 黄文燕 . 中医药治疗帕金森病的思路与方法[J]. 中西医结合学报, 2004,2(1):75-77
[14] Calabresi P, Giacomini P, Centonze D, Bernardi G . Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol. 2000; 47(4 Suppl 1):S60-S68.
[15] Gurevich VV, Gurevich EV . The structural basis of arrestin-mediated regulation of G-protein-coupled receptors[J]. Pharmacol Ther, 2006,110(3):465-502
doi: 10.1016/j.pharmthera.2005.09.008
[16] Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ . β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking[J]. Proc Natl Acad Sci U S A, 2001,98(4):1601-1606
[1] Shu-yi Chen, Qun-wei Chen, Liu-mei Shou, Hong Pan, Shan-ming Ruan, Zhe-hao Liang, Qi-jin Shu. Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with Chinese herbal medicine Pi-Yan-Ning: A case report. Journal of Integrative Medicine, 2021, 19(6): 555-560.
[2] Xin Yin, Shu-bin Cai, Lan-ting Tao, Lu-ming Chen, Zhong-de Zhang, Su-hong Xiao, Arthur Yin Fan, Xu Zou. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. Journal of Integrative Medicine, 2021, 19(5): 460-466.
[3] Bing-rong Li, Shi-yun Shao, Long Yuan, Ru Jia, Jian Sun, Qing Ji, Hua Sui, Li-hong Zhou, Yi Zhang, Hui Liu, Qi Li, Yan Wang, Bi-meng Zhang. Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis. Journal of Integrative Medicine, 2021, 19(2): 144-157.
[4] Qing-lan Wang, Yan-yan Tao, Hong-dong Xie, Cheng-hai Liu, Ping Liu. Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis. Journal of Integrative Medicine, 2020, 18(6): 505-513.
[5] Ming-sheng Lyu, De-ying Li, Shao-zhong Zhou, Cheng-jun Ban, Jun Yan. Adult-onset Still's disease successfully treated with Chinese herbal medicine: A case report with 15-month follow-up. Journal of Integrative Medicine, 2020, 18(6): 530-534.
[6] Arthur Yin Fan, Sherman Gu, Sarah Faggert Alemi, Research Group for Evidence-based Chinese Medicine. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Journal of Integrative Medicine, 2020, 18(5): 385-394.
[7] Bin Lan, Jin-wen Ge, Shao-wu Cheng, Xi-long Zheng, Jun Liao, Chao He, Zheng-qing Rao, Guo-zuo Wang. Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. Journal of Integrative Medicine, 2020, 18(4): 344-350.
[8] Sitthichai Iamsaard, Supatcharee Arun, Jaturon Burawat, Supataechasit Yannasithinon, Saranya Tongpan, Sudtida Bunsueb, Natthapol Lapyuneyong, Pannawat Choowong-in, Nareelak Tangsrisakda, Chadaporn Chaimontri, Wannisa Sukhorum. Evaluation of antioxidant capacity and reproductive toxicity of aqueous extract of Thai Mucuna pruriens seeds. Journal of Integrative Medicine, 2020, 18(3): 265-273.
[9] Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[10] Morufu Eyitayo Balogun, Elizabeth Enohnyaket Besong, Jacinta Nkechi Obimma, Ogochukwu Sophia Mbamalu, Fankou Serges Athanase Djobissie. Protective roles of Vigna subterranea (Bambara nut) in rats with aspirin-induced gastric mucosal injury. Journal of Integrative Medicine, 2018, 16(5): 342-349.
[11] Carola Analía Torres, Cristina Marisel Pérez Zamora, María Beatriz Nuñez, Ana María Gonzalez. In vitro antioxidant, antilipoxygenase and antimicrobial activities of extracts from seven climbing plants belonging to the Bignoniaceae. Journal of Integrative Medicine, 2018, 16(4): 255-262.
[12] Lucky Legbosi Nwidu, Raphael Ellis Teme. Hot aqueous leaf extract of Lasianthera africana (Icacinaceae) attenuates rifampicin-isoniazid-induced hepatotoxicity. Journal of Integrative Medicine, 2018, 16(4): 263-272.
[13] Shui-jie Shen, Yong-hong Zhang, Xiao-xia Gu, Shui-ju Jiang, Ling-jun Xu. Yangfei Kongliu Formula, a compound Chinese herbal medicine, combined with cisplatin, inhibits growth of lung cancer cells through transforming growth factor-β1 signaling pathway. Journal of Integrative Medicine, 2017, 15(3): 242-251.
[14] Liliana Zazueta-Beltrán, Lorena Medina-Aymerich, Nadia Estela Díaz-Triste, Aracely Evangelina Chávez-Piña, Gilberto Castañeda-Hernández, Leticia Cruz-Antonio. Evidence against the participation of a pharmacokinetic interaction in the protective effect of single-dose curcumin against gastrointestinal damage induced by indomethacin in rats. Journal of Integrative Medicine, 2017, 15(2): 151-157.
[15] Tom Fleischer, Tung-Ti Chang, Hung-Rong Yen. Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need. Journal of Integrative Medicine, 2016, 14(5): 322-335.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022